360 related articles for article (PubMed ID: 10845496)
1. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
Teo EL; Strouse PJ; Hernandez RJ
AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
[TBL] [Abstract][Full Text] [Related]
2. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions.
Ramani M; Reinhold C; Semelka RC; Siegelman ES; Liang L; Ascher SM; Brown JJ; Eisen RN; Bret PM
Radiology; 1997 Jan; 202(1):166-72. PubMed ID: 8988207
[TBL] [Abstract][Full Text] [Related]
3. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
4. MRI of soft-tissue tumors: fast STIR sequence as substitute for T1-weighted fat-suppressed contrast-enhanced spin-echo sequence.
Tokuda O; Harada Y; Matsunaga N
AJR Am J Roentgenol; 2009 Dec; 193(6):1607-14. PubMed ID: 19933655
[TBL] [Abstract][Full Text] [Related]
5. Soft-tissue masses: diagnosis using MR imaging.
Kransdorf MJ; Jelinek JS; Moser RP; Utz JA; Brower AC; Hudson TM; Berrey BH
AJR Am J Roentgenol; 1989 Sep; 153(3):541-7. PubMed ID: 2763953
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
[TBL] [Abstract][Full Text] [Related]
7. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
[TBL] [Abstract][Full Text] [Related]
8. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.
Bennett GL; Petersein A; Mayo-Smith WW; Hahn PF; Schima W; Saini S
AJR Am J Roentgenol; 2000 Feb; 174(2):477-85. PubMed ID: 10658728
[TBL] [Abstract][Full Text] [Related]
9. [MR imaging of intramuscular hemangiomas].
Ohgushi M; Kubota H; Yamaguchi K; Suda A
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Apr; 55(5):305-11. PubMed ID: 7784151
[TBL] [Abstract][Full Text] [Related]
10. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
11. Complex renal cysts: findings on MR imaging.
Balci NC; Semelka RC; Patt RH; Dubois D; Freeman JA; Gomez-Caminero A; Woosley JT
AJR Am J Roentgenol; 1999 Jun; 172(6):1495-500. PubMed ID: 10350279
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?
Crim JR; Seeger LL; Yao L; Chandnani V; Eckardt JJ
Radiology; 1992 Nov; 185(2):581-6. PubMed ID: 1410377
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
[TBL] [Abstract][Full Text] [Related]
16. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
[TBL] [Abstract][Full Text] [Related]
17. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
18. Statistical analysis of MRI parameters predicting malignancy in 141 soft tissue masses.
De Schepper AM; Ramon FA; Degryse HR
Rofo; 1992 Jun; 156(6):587-91. PubMed ID: 1617181
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
[TBL] [Abstract][Full Text] [Related]
20. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
